Effect of Cis-palmitoleic acid (an omega-7 fatty acid) supplementation on inflammation and expression of HNF4 γ, HNF4α and IL-6 in patients with ulcerative colitis: a double-blind, randomized pilot study.

CONCLUSIONS: Cis-palmitoleic acid as co- adjuvant therapy for 8 weeks seems to decrease the inflammatory activity through the increased expression of HNF4α and HNF4γ in patients with UC. PMID: 28185444 [PubMed - as supplied by publisher]
Source: Minerva Gastroenterologica e Dietologica - Category: Gastroenterology Tags: Minerva Gastroenterol Dietol Source Type: research